Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies.
Miller CD, Lozada JR, Zorko NA, Elliott A, Makovec A, Radovich M, Heath EI, Agarwal N, Mckay RR, Garje R, Bastos BR, Hoon DSB, Orme JJ, Sartor O, VanderWalde A, Nabhan C, Sledge G, Shenderov E, Dehm SM, Lou E, Miller JS, Hwang JH, Antonarakis ES. Miller CD, et al. Cancer Res Commun. 2024 May 30;4(5):1369-1379. doi: 10.1158/2767-9764.CRC-23-0546. Cancer Res Commun. 2024. PMID: 38709075 Free PMC article.
Germline-Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic Essentiality.
Arafa AT, Yadav S, Marshall CH, Mauer E, Huang M, Yilma B, van der Pol Y, Fragkogianni S, Teslow EA, Kellen S, Boytim E, Luo C, Ludwig M, Zhang W, Jayaraj A, Armstrong DK, Isaacs WB, Drake JM, Nguyen HD, Huang RS, Chao CY, Lou E, Dehm SM, Couch FJ, Hwang JH, Antonarakis ES. Arafa AT, et al. Clin Cancer Res. 2025 May 1;31(9):1730-1745. doi: 10.1158/1078-0432.CCR-24-2058. Clin Cancer Res. 2025. PMID: 40019487
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting.
Lozada JR, Elliott A, Evans MG, Wacker J, Storey KM, Egusa EA, Zorko NA, Kumar A, Crymes A, Heath EI, Carneiro BA, Soares HP, Cichocki F, Miller JS, Lou E, Beltran H, Antonarakis ES, Ryan CJ, Hwang JH. Lozada JR, et al. Cancer Res Commun. 2025 Feb 1;5(2):318-326. doi: 10.1158/2767-9764.CRC-24-0501. Cancer Res Commun. 2025. PMID: 39874041 Free PMC article.
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes.
Hwang J, Likasitwatanakul P, Deshmukh SK, Wu S, Kwon JJ, Toye E, Moline D, Evans MG, Elliott A, Passow R, Luo C, John E, Gandhi N, McKay RR, Heath EI, Nabhan C, Reizine N, Orme JJ, Domingo Domenech JM, Sartor O, Baca SC, Dehm SM, Antonarakis ES. Hwang J, et al. Clin Cancer Res. 2025 Mar 3;31(5):936-948. doi: 10.1158/1078-0432.CCR-24-3471. Clin Cancer Res. 2025. PMID: 39745364 Free PMC article.
HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers.
Vobugari N, Makovec A, Kellen S, Nazari SS, Elliott A, Schmeck D, Deacon A, von Dohlen G, John E, Barata PC, Agarwal N, Geller MA, Erickson BK, Sledge G, Ostrander JH, McKay RR, Ryan CJ, Sharifi N, Antonarakis ES, Hwang J. Vobugari N, et al. Int J Mol Sci. 2025 Jun 14;26(12):5720. doi: 10.3390/ijms26125720. Int J Mol Sci. 2025. PMID: 40565184 Free PMC article.